Keyphrases
Head-to-head Comparison
63%
Lung Cancer
58%
Positron Emission Tomography-computed Tomography (PET-CT)
53%
Neuroendocrine Carcinoma
52%
Neuroendocrine Tumor
47%
64Cu-DOTATATE
47%
Small Cell Lung Cancer
37%
Non-small Cell Lung Cancer (NSCLC)
36%
Ki-67 Index
35%
Neuroendocrine Neoplasms
35%
Lung Cancer Patients
33%
18F-fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET)
31%
Patient Assessment
31%
Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)
31%
Perioperative Rehabilitation
31%
Chemotherapy
27%
After Surgery
27%
Exercise Program
24%
Response Evaluation
23%
Postoperative Rehabilitation
22%
Ki-67
21%
Somatostatin Receptor 2 (SSTR2)
19%
Bronchopulmonary Neuroendocrine Tumors
18%
PET Tracer
18%
Survival Rate
18%
DOTATATE PET
17%
Octreotide
16%
Diethylenetriaminepentaacetic Acid
16%
Progression-free Survival
16%
Quality of Life
16%
Heavily Pretreated Patients
15%
Bone Scintigraphy
15%
Large Arteries
15%
Positron Emission tomography-CT
15%
Randomized Trial
15%
Monotherapy
15%
P53 Expression
15%
P53 Protein
15%
Randomized Clinical Trial
15%
Anthracycline Extravasation
15%
Dexrazoxane
15%
Advanced Stage
15%
Gene Expression Profile
15%
Supervised Exercise
15%
Risk Factors
15%
Initial Staging
15%
Tracer Uptake
15%
Exercise Intervention
15%
Surgical Treatment
15%
Usual Care
15%
Medicine and Dentistry
Lung Cancer
100%
Polyethylene Terephthalate
88%
Neuroendocrine Tumor
82%
Positron Emission Tomography-Computed Tomography
53%
Copper 64
47%
Small Cell Lung Cancer
39%
Non Small Cell Lung Cancer
38%
Quality of Life
33%
Prospective Study
32%
Gallium 68
31%
Fluorodeoxyglucose F 18
31%
Diseases
29%
Radioactive Tracer
28%
positron emission tomographic scan
27%
Surgery
26%
Functional Status
22%
Non-Small Cell Lung Cancer
22%
Somatostatin Receptor
20%
Physical Capacity
19%
Receptor Subtype
19%
Survival Rate
17%
Octreotide
16%
Pentetic Acid
16%
Indium 111
16%
Bone Scintigraphy
15%
Monotherapy
15%
Gene Expression
15%
Personalized Medicine
15%
Topotecan
15%
Fluorine-18
15%
Carcinoid
15%
Goblet Cell
15%
Cowden Syndrome
15%
Ganglioneuroblastoma
15%
Randomized Clinical Trial
15%
Atherosclerosis
15%
